Analystreport

Adverum Biotechnologies, Inc. (NASDAQ: ADVM) had its "neutral" rating re-affirmed by analysts at Chardan Capital.

Adverum Biotechnologies, Inc.  (ADVM) 
Last adverum biotechnologies, inc. earnings: 3/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: adverum.gcs-web.com/investor-overview